Literature DB >> 28249269

Roles of Ileal ASBT and OSTα-OSTβ in Regulating Bile Acid Signaling.

Paul A Dawson1.   

Abstract

BACKGROUND: In addition to their classical role as detergents, bile acids function as signaling molecules to regulate gastrointestinal physiology, carbohydrate and lipid metabolism, and energy expenditure. The pharmacodynamic potential of bile acids is dependent in part on the tight pharmacokinetic control of their concentration and metabolism, properties governed by their hepatic synthesis, enterohepatic cycling, and biotransformation via host and gut microbiota-catalyzed pathways. Key Messages: By altering the normal cycling and compartmentalization of bile acids, changes in hepatobiliary or intestinal transport can affect signaling and lead to the retention of cytotoxic hydrophobic bile acids and cell injury. This review discusses advances in our understanding of the intestinal transporters that maintain the enterohepatic cycling of bile acids, signaling via bile acid-activated nuclear and G protein receptors, and mechanisms of bile acid-induced cell injury.
CONCLUSIONS: Dysregulated expression of the Asbt and Ostα-Ostβ alters bile acid signaling via the gut-liver farnesoid X receptor-fibroblast growth factor 15/19 axis and may contribute to other bile acid-regulated metabolic and cell injury pathways.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249269      PMCID: PMC5432121          DOI: 10.1159/000450987

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  48 in total

Review 1.  Bile acids in the colon, from healthy to cytotoxic molecules.

Authors:  Juan I Barrasa; Nieves Olmo; Ma Antonia Lizarbe; Javier Turnay
Journal:  Toxicol In Vitro       Date:  2012-12-27       Impact factor: 3.500

2.  Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

Authors:  Matthew J Potthoff; Austin Potts; Tianteng He; João A G Duarte; Ronald Taussig; David J Mangelsdorf; Steven A Kliewer; Shawn C Burgess
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

3.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

4.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

Review 5.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

6.  Primary bile acid malabsorption. Histologic and immunologic study in three patients.

Authors:  O S Popović; K M Kostić; V B Milović; S Milutinović-Djurić; V D Miletić; L Sesić; M Djordjević; M Bulajić; P Bojić; M Rubinić
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

7.  Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Authors:  Sunder Mudaliar; Robert R Henry; Arun J Sanyal; Linda Morrow; Hanns-Ulrich Marschall; Mark Kipnes; Luciano Adorini; Cathi I Sciacca; Paul Clopton; Erin Castelloe; Paul Dillon; Mark Pruzanski; David Shapiro
Journal:  Gastroenterology       Date:  2013-05-30       Impact factor: 22.682

8.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  TGR5 potentiates GLP-1 secretion in response to anionic exchange resins.

Authors:  Taoufiq Harach; Thijs W H Pols; Mitsunori Nomura; Adriano Maida; Mitsuhiro Watanabe; Johan Auwerx; Kristina Schoonjans
Journal:  Sci Rep       Date:  2012-05-30       Impact factor: 4.379

10.  Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.

Authors:  Martina Düfer; Katrin Hörth; Rebecca Wagner; Björn Schittenhelm; Susanne Prowald; Thomas F J Wagner; Johannes Oberwinkler; Robert Lukowski; Frank J Gonzalez; Peter Krippeit-Drews; Gisela Drews
Journal:  Diabetes       Date:  2012-04-09       Impact factor: 9.461

View more
  8 in total

1.  Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice.

Authors:  Ivo P van de Peppel; Anna Bertolini; Theo H van Dijk; Albert K Groen; Johan W Jonker; Henkjan J Verkade
Journal:  J Lipid Res       Date:  2019-07-19       Impact factor: 5.922

2.  Transcription factor Klf9 controls bile acid reabsorption and enterohepatic circulation in mice via promoting intestinal Asbt expression.

Authors:  Shuang Liu; Man Liu; Meng-Lin Zhang; Cui-Zhe Wang; Yin-Liang Zhang; Yu-Jie Zhang; Chun-Yuan Du; Su-Fang Sheng; Wei Wang; Ya-Tong Fan; Jia-Ni Song; Jin-Can Huang; Yue-Yao Feng; Wei Qiao; Jin-Long Huang; Yu-Hui Li; Lu Zhou; Jun Zhang; Yong-Sheng Chang
Journal:  Acta Pharmacol Sin       Date:  2022-02-01       Impact factor: 7.169

3.  A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.

Authors:  Mohammed Nabil Quraishi; Animesh Acharjee; Andrew D Beggs; Richard Horniblow; Chris Tselepis; Georgios Gkoutos; Subrata Ghosh; A E Rossiter; Nicholas Loman; Willem van Schaik; David Withers; Julian R F Walters; Gideon M Hirschfield; Tariq H Iqbal
Journal:  J Crohns Colitis       Date:  2020-07-30       Impact factor: 9.071

4.  Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.

Authors:  Madeleine Spatz; Dragos Ciocan; Gregory Merlen; Dominique Rainteau; Lydie Humbert; Neuza Gomes-Rochette; Cindy Hugot; Nicolas Trainel; Françoise Mercier-Nomé; Séverine Domenichini; Virginie Puchois; Laura Wrzosek; Gladys Ferrere; Thierry Tordjmann; Gabriel Perlemuter; Anne-Marie Cassard
Journal:  JHEP Rep       Date:  2021-01-19

5.  Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression.

Authors:  Rune Rose Tronstad; Siren Berland; Erling Tjora; Khadija El Jellas; Ingvild Aukrust; Kurt Kristensen; Dag Tveitnes; Anders Molven; Hanns-Ulrich Marschall; Anuradha Rao; Paul A Dawson
Journal:  JPGN Rep       Date:  2022-07-25

Review 6.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

Review 7.  Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases.

Authors:  Vik Meadows; Lindsey Kennedy; Debjyoti Kundu; Gianfranco Alpini; Heather Francis
Journal:  Front Med (Lausanne)       Date:  2020-01-29

8.  A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats.

Authors:  Ninghua Jiang; Bohong Zheng; Yihan Feng; Lei Yin; Yuanrong Liu; Lujing Cao; Ning Zheng; Suxiang Wu; Baoyue Ding; Xuan Huang; Jeffrey Wang; Shuyu Zhan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.